SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Bayer HealthCare's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in Non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis